Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

22nd Century Group, Inc. (XXII)

1.18   -0.01 (-0.84%) 11-25 13:00
Open: 1.19 Pre. Close: 1.19
High: 1.19 Low: 1.14
Volume: 299,407 Market Cap: 254(M)

Technical analysis

as of: 2022-11-25 2:01:39 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 1.49     One year: 1.69
Support: Support1: 1    Support2: 0.83
Resistance: Resistance1: 1.27    Resistance2: 1.45
Pivot: 1.2
Moving Average: MA(5): 1.17     MA(20): 1.21
MA(100): 1.39     MA(250): 1.86
MACD: MACD(12,26): -0.1     Signal(9): 0
Stochastic oscillator: %K(14,3): 41.4     %D(3): 36.7
RSI: RSI(14): 48.8
52-week: High: 3.51  Low: 0.85
Average Vol(K): 3-Month: 1,805 (K)  10-Days: 1,556 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
[ XXII ] has closed above bottom band by 41.6%. Bollinger Bands are 34.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.2 - 1.2 1.2 - 1.21
Low: 1.1 - 1.11 1.11 - 1.12
Close: 1.18 - 1.19 1.19 - 1.2

Company Description

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Headline News

Fri, 25 Nov 2022
Is 22nd Century Group Inc (XXII) Stock About to Get Hot Friday? - InvestorsObserver

Mon, 21 Nov 2022
2022-11-21 | NDAQ:XXII | Press Release | 22nd Century Group Inc - Stockhouse

Wed, 16 Nov 2022
Gay Bowl XXII Hawaii - San Francisco Bay Times - San Francisco Bay Times

Wed, 16 Nov 2022
22nd Century Group, Inc.: Destined For Prolonged Success (NASDAQ:XXII) - Seeking Alpha

Mon, 14 Nov 2022
22nd Century Group (Nasdaq: XXII) to Participate in November 2022 Investor Conferences - GlobeNewswire

Tue, 08 Nov 2022
22nd Century Group, Inc. (XXII) Q3 2022 Earnings Call Transcript - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Underperform
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Consumer Defensive
Industry:  Tobacco
Shares Out. 215 (M)
Shares Float 213 (M)
% Held by Insiders 2.5 (%)
% Held by Institutions 21.3 (%)
Shares Short 16,120 (K)
Shares Short P.Month 15,710 (K)

Stock Financials

EPS -0.23
EPS Est Next Qtl -0.02
EPS Est This Year -0.11
EPS Est Next Year -0.08
Book Value (p.s.) 0.56
Profit Margin (%) -96.7
Operating Margin (%) -83.5
Return on Assets (ttm) -22.5
Return on Equity (ttm) -47.5
Qtrly Rev. Growth 203.3
Gross Profit (p.s.) 0
Sales Per Share 0.22
EBITDA (p.s.) -0.18
Qtrly Earnings Growth 0
Operating Cash Flow -37 (M)
Levered Free Cash Flow -27 (M)

Stock Valuations

PE Ratio -5.2
PEG Ratio 0
Price to Book value 2.1
Price to Sales 5.17
Price to Cash Flow -6.82

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.